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ABSTRACT The lysozyme of bacteriophage T7 is a bi-
functional protein that cuts amide bonds in the bacterial cell
wall and binds to and inhibits transcription by T7 RNA
polymerase. The structure of a mutant T7 lysozyme has been
determined by x-ray crystallography and rermed at 2.2-
resolution. The protein folds into an a/.ssheet structure that
has a prominent cleft. A zinc atom Is located in the cleft, bound
directly to three amino acids and, through a water molecule, to
a fourth. Zinc is required for amidase activity but not for
inhibition ofT7RNA polymerase. Aligment ofthe zinc ligands
of ¶7 lysozyme with those of carboxypeptidase A and thermol-
ysin suggests structural similarity among the catalytic sites for
the amdase and these zinc proteases. Mutational analysis
identified presumed catalytic residues for amidase activity
within the deft and a surface that appears to be the site of
bnding to ¶7 RNA polymerase. Binding of T7 RNA polymer-
ase inhibits amidase activity.
Although named for its lytic activity, T7 lysozyme also binds
specifically to T7 RNA polymerase and inhibits transcription
(1). This interaction provides a feedback mechanism that
shuts off late transcription during 17 infection and also
stimulates DNA replication (refs. 1-4; X.Z. and F.W.S.,
unpublished data). The ability to inhibit transcription has
made 17 lysozyme widely used for controlling basal expres-
sion in a gene expression system based on T7 RNA poly-
merase (5, 6). ¶7 lysozyme differs from the previously
well-studied egg-white and phage T4 lysozymes not only in
having an interaction with T7RNA polymerase but also in the
chemistry of lysis: it cuts the amide bond between N-acetyl-
muramic acid and L-alanine rather than the glycosidic bond
between N-acetylmuramic acid and N-acetylglucosamine in
the peptidoglycan layer of bacterial cell walls (7). We ex-
pected that knowledge ofthe structure ofT7 lysozyme would
help us to understand how its dual activities are accommo-
dated in a protein of only 150 amino acids (8).
EXPERIMENTAL PROCEDURES
Expression, Purification, and Crystallization. Base pairs
10,706-11,161 of T7 DNA code for T7 lysozyme (8). Se-
quencing oflysozyme clones revealed that nucleotides 11,061
and 11,062 of 17 DNA are TG instead of GT, a result
confirmed in wild-type T7 DNA. Therefore, amino acid 118
ofT7 lysozyme is predicted to be valine instead ofglycine, as
also observed in the crystal structure. An Ava II-Ase I
fragment (base pairs 10,664-11,164) was cloned between the
*10 promoter and To terminator for T7 RNA polymerase in
the pET-3 expression vector (6) to give plasmid pAR4593, the
source of wild-type lysozyme. The AK6 mutation, which
deletes amino acids 2-5 of wild-type lysozyme, was made byjoining aDra I-EcoRI fragment coding for amino acids 6-150
ofT7 lysozyme (from pAR4593) to the Nhe I-EcoRI fragment
that contains the T71ac promoter and slO translation start
from pET-lid (6), producing pAR4617. The Nhe I site of the
latter fragment was partly filled in, using G and A, and the
protruding A and G were trimmed with mung bean nuclease
before blunt-end ligation, so that the initiating Met-Ala was
fused to Lys6 of T7 lysozyme. Wild-type or AK6 mutant
lysozyme was produced from these plasmids in Escherichia
coli HMS174(DE3) by inducing T7 RNA polymerase with
isopropyl /-D-thiogalactopyranoside as described (6).
Purification of the proteins was modified from that previ-
ously described for T7 lysozyme (1). Cleared lysate was
passed through a DE52 column (Whatman), and the flow-
through was applied to a Mono S column (Pharmacia FPLC)
and eluted with a gradient of 10-400 mM NaCl. Buffers
contained 0.1 mM ZnSO4. Crystals of AK6 lysozyme were
grown by mixing 5 id of protein solution (10 mg/ml in 20mM
Hepes, pH 7.0/250 mM NaCl/0.1 mM ZnSO4/5 mM 2-mer-
captoethanol) with an equal volume of 20% (wt/vol) poly-
ethylene glycol 4000/50 mM ammonium sulfate/50 mM so-
dium citrate at pH 6.6 and equilibrating the mixture against
1 ml of the latter solution.
Mercuric chloride derivatives were obtained by growing
crystals in mother liquor saturated with mercuric chloride,
since the conventional soaking method caused cracking of
already formed crystals. The cocrystals were isomorphous
and showed a single mercury site in both difference and
anomalous Patterson maps. Derivatives were also obtained
by soaking native crystals in 0.5 mM p-chloromercuriben-
zenesulfonic acid for 1 week. Both mercury compounds
reacted with Cys18.
Data Cofection and Structure Determination. Crystallo-
graphic information for AK6 mutant lysozyme is given in
Table 1.0 The diffraction intensities were measured at 160C
on a FAST area detector with CuK. radiation (1.54 A)
generated by an Elliott GX-21 rotating anode: the exposure
times were 100-180 sec for 0.10 of rotation at 45 kV and 95
mA, and the detector was run at a gain setting of SETDET 7
7. Data acquisition and processing were under the control of
MADNES software (9). Each reflection profile was analyzed by
the method of Kabsch (10). The data sets were divided into
sectors each containing roughly 1000-2000 reflections for
scaling with the program FS (11). Heavy-atom parameters
were refined and initial phases were calculated with the
program PROTEIN (12). The model was built by using the
program FRODO (13) with three rounds of phase combination
of the atomic model with the MIRAs phase using COMBINE
(written by W. Kabsch). The initial atomic model was refined
against 2.5-A native data by using the program X-PLOR (14).
One hundred steps of Powell optimization smoothly reduced
the R factor from 0.40 to 0.277 with no manual intervention.
One cycle of simulated annealing refinement was then carried
tThe atomic coordinates have been deposited in the Protein Data
Bank, Chemistry Department, Brookhaven National Laboratory,
Upton, NY 11973 (reference iLBA).
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Table 1. X-ray data from crystals of AK6 mutant T7 lysozyme
(F > 2aF)
p-Chloromercuri-
Native HgCl2 benzenesulfonate
Resolution, A 2.2 2.5 2.8
No. of reflections
Observed 42,968 24,579 7,270
Unique 7,142 3,582 3,055
Rmerge,* % 8.61 9.30 5.07
No. of crystals 5 5 2
Phasing power (2.5 A)t 3.77 2.73
Mean figure of merit 0.80
*Rmerge = III - (J)I/X(J), where I is the observed intensity and (1) is
the averaged intensity obtained from multiple observations of
symmetry-related reflections.
tPhasing power = rms ((FH)/E), where FH is the heavy-atom
structure-factor amplitude and E is residual lack of closure.
out, using initial and final temperatures of 3000 K and 350 K,
respectively, reducing the R factor to 0.24. A total of five
rounds of manual rebuilding using FRODO and least-squares
refinement using X-PLOR were then carried out. The resolu-
tion of the native data was extended to 2.2 A, and only 26
well-resolved bound water molecules were included. The R
factor is 0.19 for 6991 reflections within the resolution range
of 10 to 2.2 A. The final model has root-mean-square devi-
ations from ideal bond distances and angles of 0.017 A and
3.30, respectively. All main-chain ) and q angles are within
allowed regions.
The data sets of wild-type T7 lysozyme were collected
using 1.15-A wavelength at beamline X12-C at the National
Synchrotron Light Source, Brookhaven National Labora-
tory. The refined AK6 coordinates were used as the initial
model of the wild-type lysozyme and refined for 4067 unique
reflections measured between 10 to 2.7 A with F > 2oF.
Positional refinement, with the program X-PLOR, reduced the
R factor from 0.427 to 0.276.
Assay of Amidase Activity. Amidase activity was assayed
by measuring the decrease in turbidity of E. coli C600 cells
that had been incubated in 0.1 M EDTA for 5 min at room
temperature, pelleted, suspended in 10 mM potassium phos-
phate (pH 7.0), and kept on ice until use (15). A few minutes
before assay, lysozyme fractions (about 1 mg/ml) were
diluted on ice in 20 mM Hepes, pH 7.0/10 mM NaCl/5 mM
2-mercaptoethanol containing bovine serum albumin (100
Mg/ml) and either 2 mM EDTA or 2 mM ZnSO4. To measure
activity, 10 t4 of diluted enzyme was added to 1 ml of
sensitized cells that had been brought to room temperature,
and the change in 0D600 was recorded at intervals. Enzyme
dilutions that decreased the turbidity at a maximum rate of
about 0.02-0.04 OD600 unit/mmn were used to calculate ac-
tivities; 1 unit of activity was defined as the amount of
enzyme that reduced OD6oo at the rate of 0.001/min.
RESULTS AND DISCUSSION
Crystaflization and Structure Determination. Attempts to
crystallize wild-type 17 lysozyme were initially unsuccess-
ful, but a mutant lysozyme that lacks four amino acids near
the N terminus crystallized readily. This mutant, AK6, lacks
amino acids 2-5 (Arg-Val-Gln-Phe) of the wild-type protein.
The mutant protein has normal amidase activity but is
completely unable to bind or inhibit T7 RNA polymerase.
The AK6 mutant protein was produced from the cloned
gene and purified in the presence of Zn2+ because 17 lyso-
zyme had been found to contain zinc (J. Flanagan and K.
MacKenzie, personal communication). Under appropriate
conditions, crystals of the purified protein began to appear
within 10 min and reached a size of 0.5 mm x 0.6 mm x 1.5
mm overnight. The crystals formed in space group C222,
with unit cell dimensions a = 46.5 A, b = 62.5 A, and c =
110.0 A. There is one molecule in each of the eight asym-
metric units. Initial 2.5-A phases were obtained by multiple
isomorphous replacement from two mercury derivatives to-
gether with their anomalous scattering contributions (Table
1). The phases produced electron density maps that enabled
us to trace the polypeptide backbone and fit the complete
sequence of 146 amino acids.
We also obtained crystals of wild-type T7 lysozyme by
seeding first with microcrystals of AK6 mutant protein and
then with microcrystals of the wild-type protein. These
crystals took weeks rather than hours to grow and diffracted
to a resolution of about 2.7 A. They were isomorphous to the
AK6 crystals, and the wild-type structure was solved by
difference Fourier analysis. The only significant difference
was at the N terminus, where the wild-type protein has four
additional residues. The N-terminal residues of the AK6
structure are flexible (higher temperature factor), and the
additional residues in the wild-type structure are completely
disordered.
Protein Structure. Two views of the structure of the AK6
mutant lysozyme and a diagram of the locations of structural
elements in the amino acid sequence are shown in Fig. 1. The
protein contains five (3-strands and three a-helices, designated
(1, aA, (32, (33, (34, aB, (35, and aC in order from N to C
terminus ofthe amino acid sequence. The loops between these
structures are designated 1A, A2, 23, 34, 4B, B5, and SC. The
structure contains a central sheet of the five (-strands, four
parallel and one, (33, antiparallel. The 18-residue aB and the
5-residue aC lie below the sheet, while a combination of the
11-residue aA and four ofthe loops extend above the sheet on
two sides to form a cleft that has the Zn2+ ion near its bottom.
This cleft is 22-26 A long and 10-11 A deep with a wider end,
20 A backbone-to-backbone, flanked by aA4oop A2 and loop
4B, and a narrower end, 8 A, flanked by loops 34 and SC.
The Zn2+ is firmly anchored to the protein by three side-
chain ligands, His17, HisU22, and Cys13', and connected to the
hydroxyl group of Tyr46 through a water molecule (Fig. 1D).
The Zn-ligand bond distances are 2.15 A (Zn-S, Cys130), 2.52
A (Zn-N, His17), 2.67 A (Zn-N, His'22), and 2.83 A (Zn-O,
water molecule) and have nearly tetrahedral geometry. The
distance between the hydroxyl group of Tyr4 and the water
molecule is 3.02 A. The Zn-ligand bond distances were not
constrained during refinement. His'n and Cys'30 are on one
side of the cleft in loop 5C, His17 is in strand (31 at the bottom
ofthe cleft, and Tyr 6 is in loop A2 on the other side ofthe cleft
from His'2 and Cys'30.
In the AK6 crystal, the N-terminal amino group of one
molecule extends toward the cleft of the neighboring mole-
cule, contacting the side chains of Trp35 and Glu38 in aA.
Apparently, the additional four amino acids at the N terminus
of wild-type 17 lysozyme are not easily accommodated in the
crystal structure, as reflected both in the difficulty of crys-
tallizing the wild-type protein and in the disorder of the
N-terminal residues.
Zinc Is Required for Amidase Activity but Not for Inhibition
of Transcription. The position of Zn2+ at the bottom of the
cleft and its coordination to a water molecule make it seem
likely to be a cofactor for the amidase activity of T7 lyso-
zyme. Coordination to three protein ligands and a water
molecule is found universally in enzymes in which Zn2+ has
a catalytic role, whereas coordination directly to four protein
ligands is typical in proteins where Zn2+ atoms play a
structural role (16).
Wild-type T7 lysozyme purified in the absence of added
Zn2+ typically resolves into two or more peaks upon column
chromatography, an observation that led to the discovery
that 17 lysozyme contains zinc (J. Flanagan and K. Mac-
Kenzie, personal communication). The profile shown in Fig.
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FIG. 2. Amidase activities of different fractions of 17 lysozyme
purified in the absence of added Zn2+. (A) Profile of Wild-type 17
lysozyme chromatographed on a Mono S column. Peaks 1-5 were
collected in separate fractions. (B) Amidase activity in the absence
(-) or presence (+) of Zn2 . Amidase activities are plotted relative
to that of fraction 5 in the presence of Zn2+. In this experiment, the
specific activity of hen egg-white lysozyme was about 200 x 103
units/mg and that of the Zn2+-containing fraction 5 was about 1800
x 103 units/mg, comparable to that observed for 17 lysozyme that
had been purified in the presence of Zn2 .
2A has five peaks, which were fractionated and assayed for
activity. All five fractions had comparable ability to inhibit
transcription by purified T7 RNA polymerase in the absence
of added Zn2 , and all bound T7 RNA polymerase equally
well in a gel assay in the absence of any divalent ion.
However, these fractions differed markedly in amidase ac-
tivity, as measured in a lysozyme assay with EDTA-treated
E. coli cells (Fig. 2B).
Fraction 5 had full amidase activity in the presence or
absence ofadded Zn2+, similar to 17 lysozyme purified in the
presence of Zn2+, and presumably contained fully active
protein that had retained Zn2I through the purification.
Fraction 3 had undetectable amidase activity in the absence
of Zn2+ but fill activity in its presence. Apparently the
protein in fraction 3 was inactive because it had lost Zn2+ but
could recover full amidase activity when Zn2+ was added.
Consistent with this interpretation, o-phenanthroline, a
strong Zn2+ chelator, gradually inactivated the amidase ac-
tivity of fraction 5, but activity was restored by adding Zn2+.
FIG. 1. Structure of17 lysozyme mutant AK6. (A) Looking down
on the cleft from above, which allows easy tracing of the chain. (B)
Looking through the cleft from the wide end to the narrow end,
approximately from upper right to lower left in A. The left side ofthe
cleft is formed by aA-loop A2 and loop 34, the right side by loops 4B
and SC. The wide end ofthe cleft, at the front, is flanked by aA-loop
A2 and loop 4B; the narrow end, at the back, is flanked by loops 34
and SC. (C) Locations of structural elements in the amino acid
sequence. (1)) Same view as in B, showing side chains of certain
amino acids implicated in amidase activity (unshaded) or inhibition
of T7 RNA polymerase (darkly shaded). Trp4l and His36 are shown
with intermediate shading because replacements of these residues
have intermediate effects on both activities.
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Table 2. Properties of T7 lysozyme mutants
Mutation*
A1MD
R2S
V3G
F5L
F5S
R8C
R8H
H17Q
H17N
H17R
R3OH
E31Q
E31K
R33S
R33L
R33H
Q34R
W35L
W35H
W35S
W35C
W35F
H36N
H36C
H36Q
H36Y
H36R
E38G
Q39E
Q39H
Q39R
G40R
G40V
W41C
W41S
W41L
W41R
L42F
L421
L42P
L42R
Y46F
Y46L
Y46D
G59E
S76Y
G83D
LllOP
A117D
K128N
K128T
K128Q
K128W
K128Y
K128M
K128I
Structural Suppressor Polymerase Amidase
element(s) mutationt inhibitiont activity1
Sup
Sup
Sup
Sup
Sup
Sup
Sup
,B1, Zn
aA
aA
aA
aA
aA
+
Sup
Sup
Sup
Sup
Sup
aA
aA
aA
A2
A2
Sup
Sup
Sup
A2
A2, Zn-H20
f33
34
4B
aB
,t5
5C
Sup
Sup
+++
+++
+++
++
++
++
++
++
++
++
++
++
Sup
Sup
Sup
Sup
Sup
Suppressor mutations are described in the text. The other muta-
tions were generated by site-directed mutagenesis of a clone of T7
lysozyme in the pALTER-1 vector (Promega) under the control of a
T7 promoter in the Altered Sites mutagenesis system (Promega) using
oligonucleotides with a degenerate sequence at the target codon.
*Mutations are identified by the one-letter code for the wild-type
amino acid followed by the residue number and then the one-letter
code for the mutant amino acid. Mutations were identified and
amino acid substitutions were inferred from DNA sequencing.
tSup mutations should have reduced inhibition of T7 RNA polymer-
ase.
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Fractions 1 and 4 behaved similarly to fractions 3 and 5,
except that their maximum amidase activity in the presence
of Zn2+ was only about 10% that of fractions 3 and 5. Most
of the activity of fraction 2 in the presence of Zn2+ was
probably due to contamination with the protein of fraction 3.
Some other factor must have limited the amidase activity of
the proteins in fractions 1, 2, and 4, but not their ability to
inhibit polymerase. We did not determine what other fac-
tor(s) might have been responsible.
We tested whether metal ions other than Zn2+ could
activate the amidase of fraction 3. Addition of Mg2+ had no
effect, Ca2+ had little if any effect, Mn2+ appeared to stim-
ulate some activity, and Co2+ stimulated full activity.
Clearly, the naturally occurring Zn2+ is essential for the
amidase activity of T7 lysozyme but not for its ability to
inhibit T7RNA polymerase. Thus, Zn2+ seems likely to have
a catalytic function but unlikely to have an important struc-
tural role.
Amidase Catalytic Site. Being an amidase, Ti lysozyme
might be expected to have a catalytic action similar to that of
two well-characterized Zn2+ proteases, carboxypeptidase A
(17) and thermolysin (18), which have similar active sites and
similar catalytic mechanisms. Critical steps in the proposed
general base mechanism for catalysis by these two enzymes
include (i) interaction of a positively charged residue (Arg127
in carboxypeptidase A and His231 in thermolysin) with the
substrate carbonyl; (ii) nucleophilic attack by a water mol-
ecule, promoted by the Zn2+ and a negatively charged residue
(Glu270 in carboxypeptidase A and Glul43 in thermolysin); and
(iii) resolution ofthe intermediate and donation ofa hydrogen
to the leaving amino group.
We identified potential catalytic residues within the cleft by
superimposing the Zn2+ and the three protein ligands of T7
lysozyme with those ofcarboxypeptidase A and thermolysin.
The bond angles between Zn2+ ligands could be aligned
closely in only one orientation, where His122, Cys130, and
Hisl7 in T7 lysozyme correspond to His69, Glu72, and His'%
in carboxypeptidase A and to Glu'66, His146, and His142 in
thermolysin. In this superposition, Lys128 of T7 lysozyme is
in the position of the positively charged residue in the two
proteases and Tyr46 is in the position of the negatively
charged residue, suggesting that these two residues may have
a critical role in catalysis.
Results of site-directed mutagenesis support the idea that
Lys'28 and Tyr`6 are important for amidase activity (Table 2).
All seven substitutions obtained for Lys"m abolished or greatly
reduced amidase activity while retaining full inhibition of T7
RNA polymerase. Both of the two substitutions that retained
slight residual activity, Asn and Thr, would have the potential
to form a hydrogen bond with the carbonyl oxygen of the
substrate amide, consistent with Lys'm functioning by inter-
acting with this group. Replacing Tyr46with Phe also abolished
amidase activity without affecting the ability to inhibit tran-
scription, consistent with a role for the tyrosine hydroxyl
group in activating the water molecule. Replacing Tyr6 with
Leu or Asp rather than Phe abolished both amidase and
inhibitory activity, suggesting that the aromatic ring of Tyr46
may have a significant structural role as well.
Substitutions were also made for His17, one of the three
Zn2+ ligands (Table 2). As expected, all three substitutions
*Inhibition of T7 RNA polymerase was estimated from the plaque
size ofwild-type T7 plated on E. coli HMS174 containing the mutant
plasmid (1): normal plaques indicated no inhibition (-) and tiny
plaques full inhibition (+ + +).§Amidase activity was estimated by ability of chloroform to lyse a
mid-logarithmic tryptone broth culture of E. coli HMS174 contain-
ing the mutant plasmid: ++ +, clearing in 1-2 min; + +, clearing in
3-5 min; +, viscous in 1-2 min and partial clearing in 3-5 min; +,
viscous in 3-5 min but only slight clearing by 5 min; -, no sign of
lysis after 3 hr.
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eliminated amidase activity. However, these mutants also
lost at least some ability to inhibit 17 RNA polymerase,
suggesting that these substitutions also affected the structure
more generally.
Comparison with Other Lysozymes. T7 lysozyme has a lytic
activity similar to that ofegg-white or T4 lysozyme, but it cuts
a different bond in the peptidoglycan layer (7) and, even
though all three proteins have a cleft (19), is structurally very
different from them. The critical residues for catalysis by
egg-white and T4 lysozyme are glutamic and aspartic residues
located on opposite sides of the cleft, but no acidic residues
are found inside the cleft of T7 lysozyme. In contrast to the
other lysozymes, T7 lysozyme had no apparent activity
against the Gram-positive bacterium Micrococcus lysodeik-
ticus, a usual substrate in lysozyme assays. This observation
may offer an approach to learning more about the substrate
specificity of T7 lysozyme and may also have evolutionary
significance, since T7-like phages have been found to infect
a range of Gram-negative bacteria (20) but have not been
reported for Gram-positive bacteria.
Interaction with 17 RNA Polymerase. In contrast to mul-
tifunctional proteins that contain multiple domains, the bi-
functional T7 lysozyme is a single-domain globular protein.
The cleft is clearly the site of amidase activity. What is the
site of interaction with T7 RNA polymerase?
We have done considerable mutational analysis of the
interaction between 17 RNA polymerase and 17 lysozyme
(X.Z. and F.W.S., unpublished data). Several mutations in
T7 RNA polymerase prevent phage growth because the
mutant polymerase is hypersensitive to inhibition by T7
Iysozyme. Suppressor mutations that allow such phages to
grow were all in T7 lysozyme. These mutant lysozymes
should be deficient in the ability to interact with T7 RNA
polymerase but retain enough amidase activity to form a
plaque, and deficiency in binding or inhibition of 17 RNA
polymerase was confirmed directly for several of them. The
site of each suppressor mutation was determined by DNA
sequencing of 30 such mutants, which affected 16 different
amino acids in T7 lysozyme (Table 2).
The N terminus ofT7 lysozyme appears to be important in
interacting with T7 RNA polymerase, since suppressor mu-
tations were found in five of the first eight amino acids. (The
AK6 mutant, lacking residues 2-5, was constructed because
of these results.) A second cluster of suppressors affected six
amino acids between residues 30 and 42 on the outer side of
helix aA and near the beginning of the A2 loop (Fig. 1D). A
surface involving this region and the N terminus (which in
wild-type lysozyme would contain four more residues) seems
likely to be the site of interaction with T7 RNA polymerase.
Suppressors at residues 59 (the end of (33), 76 (ust ahead of
,(4), and 117 (at the beginning of (85) are in the same general
area. However, they and the two suppressors at residues 83
(past the end of (34) and 110 (near the end of aB) are buried
in the structure and seem more likely to exert their effect on
the structure as a whole.
Helix aA seems to be part of the surface that interacts with
T7 RNA polymerase, but it also forms a part of one wall of
the cleft and could, therefore, be involved in binding the
amidase substrate. To investigate this further, we mutated
additional residues of aA (Table 2). Replacement of Glu3' by
Lys eliminated the ability to inhibit polymerase without
affecting amidase activity, but replacement by Gln had no
effect. Five different replacements of Trp35 and four replace-
ments of Gln39, both on the inner side of the cleft, had little
effect on either activity. On the other hand, replacement of
His36, also on the inner side of the cleft, and Trp41, in the
beginning of loop A2, had variable effects, usually affecting
amidase activity more than polymerase inhibition. The outer
surface of helix aA certainly seems to be involved in inter-
action with T7 RNA polymerase, but it is not clear to what
extent the inner surface may interact with the amidase
substrate.
The 883-amino acid T7 RNA polymerase is much larger
than the 150-amino acid T7 lysozyme, and its binding to one
side of the cleft might be expected to block the entry of the
amidase substrate or to interfere more directly with the
catalytic process. Indeed, we found that a slight molar excess
of polymerase over lysozyme strongly inhibited the amidase
activity of wild-type but not AK6 lysozyme. Perhaps this
inhibition has a role in controlling lysis during T7 infection.
Physiological Role. T7 lysozyme combines two seemingly
unrelated functions in one small protein. These functions are
not separated into independent domains, and an individual
molecule seems able to perform only one function at a time.
This mutual exclusion may be important for the sequential
functioning ofT7 lysozyme during T7 infection, where in the
middle stages it provides a feedback mechanism for control-
ling transcription and in the late stages it participates in lysis.
The interaction between T7 lysozyme and T7 RNA polymer-
ase is also related somehow to replication (1, 2), and repli-
cation is related to lysis (2, 21). T7 lysozyme appears to be a
link among these processes, and knowledge of its structure,
together with the recently determined structure of T7 RNA
polymerase (22), should aid in elucidation of their intercon-
nections.
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